Methyl-1-Test by Dragon Pharma

Dragon Pharma Original Formula

Methyl-1-Testosterone

M1T10 mg/tab
Class Oral AAS (17α-methyl DHB)
Half-Life ~5–6 hours
Anabolic Ratio ~910–1,600
Androgenic Ratio ~100–200
Pack 100 tabs
Form Oral Tablet
Availability: In Stock
$50.00
Quantity
Shipping
Wishlist

Methyl-1-Testosterone — M1T by Dragon Pharma

M1T is Dragon Pharma's formulation of oral Methyl-1-Testosterone at 10mg per tablet — among the most anabolically potent oral steroids available, with reported anabolic ratios between 910 and 1,600 depending on the assay. Despite producing mass gains comparable to Dianabol, M1T does not aromatise — producing dry, keepable gains without the estrogenic water retention that limits Dianabol's off-season results. Supplied in a 100-tablet pack.

Also searched as: M1T, Methyl-1-Test, Methyl-1-Testosterone 10mg, M1T oral steroid Dragon Pharma.

What M1T Actually Is — The Structural Misunderstanding

Methyl-1-Testosterone is one of the most frequently misidentified compounds in oral steroid literature — competitor content almost universally describes it incorrectly:

  • M1T is NOT methylated Testosterone. It is the 17-alpha-methylated version of 1-Testosterone (also known as DHB — dihydroboldenone, or 1-dihydrotestosterone)
  • 1-Testosterone (the non-methylated parent compound) is the active form found in 1-Test Cyp (DHB) — an injectable compound with a high anabolic-to-androgenic ratio
  • Adding a 17-alpha-methyl group to 1-Testosterone creates oral bioavailability — and dramatically increases the compound's anabolic potency in oral bioassays
  • Structurally, M1T is closer to Dihydroboldenone than to testosterone — its DHT-like base structure is why it does not aromatise

Why M1T Does Not Aromatise Despite Producing Dianabol-Like Gains

This combination — Dianabol-level mass gains without aromatisation — is M1T's defining characteristic and the least well-explained aspect of the compound:

  • Aromatisation requires the A-ring structure of testosterone — specifically the C-19 methyl group that aromatase removes to create estrogen's aromatic ring
  • 1-Testosterone (M1T's parent compound) already has the C1-C2 double bond that significantly alters the A-ring structure, making aromatase processing of it very inefficient
  • The DHT-like base of 1-Testosterone combined with the 17-alpha-methylation produces a compound with extremely high androgen receptor binding affinity and anabolic activity — but without the structural features aromatase requires
  • Practical consequence: M1T produces rapid mass gains through direct AR binding with high anabolic receptor signalling — without estrogen conversion, without water retention driven by estrogenic activity, and without requiring an AI

M1T as a "Prohormone" — The Regulatory History

Like Superdrol, M1T has a documented history as a legal supplement that provides unique real-world data:

  • From approximately 2003 to 2004, Methyl-1-Testosterone was sold legally in the United States as a "prohormone" dietary supplement before the Anabolic Steroid Control Act of 2004 added it to the Schedule III controlled substances list
  • This brief legal window generated documented user reports and some case study data from healthy individuals — providing a real-world efficacy and side effect profile that purely underground compounds lack
  • User reports from this period consistently documented rapid strength and mass gains at doses as low as 5-10mg/day — often described as "more dramatic than equivalent Dianabol doses" with significantly less water retention

M1T vs Dianabol vs Superdrol — The Dry Oral Mass Comparison

Parameter M1T Dianabol Superdrol
Anabolic ratio ~910–1,600 210 400
Androgenic ratio ~100–200 60 20
Aromatisation None — DHB base Significant None — DHT base
Water retention Minimal — dry gains High — wet gains Minimal — dry gains
Strength gains Very rapid, significant Rapid, significant Significant, comparable to M1T
Hepatotoxicity Significant Moderate Severe
Lethargy Pronounced — commonly reported Mild Pronounced
AI required No — no aromatisation Yes or SERM No — no aromatisation

Effects and Benefits

  • Rapid, dry lean mass gains — anabolic ratio significantly higher than Dianabol without Dianabol's estrogenic water retention
  • Significant strength increases, often described as the fastest strength-per-milligram of any oral steroid at equivalent doses
  • No aromatisation — no AI required, no gynecomastia risk from the compound itself
  • Higher keepable lean mass fraction post-cycle compared to Dianabol
  • Active at very low doses — 5-10mg/day produces meaningful effects, unusually potent per tablet

Dosage and Administration

Experience Level Typical Dose Cycle Length
Beginner (first M1T cycle) 5–10 mg/day 2–3 weeks
Intermediate 10–20 mg/day 2–4 weeks
Advanced 20–30 mg/day 2–4 weeks maximum

M1T's pronounced hepatotoxicity and the severity of its lethargy side effect make cycle lengths significantly shorter than other oral steroids — typically 2-4 weeks rather than the 4-6 weeks sometimes used with Dianabol or Anadrol. The 10mg tablet from Dragon Pharma can be split for the 5mg starting dose recommended for first-time users, or used whole for the standard 10mg daily dose. Due to its ~5-6 hour half-life, twice-daily dosing maintains more stable blood levels.

Advanced compound — short cycles only. M1T's combination of extreme anabolic potency and significant hepatotoxicity requires strict cycle length limits of 2-4 weeks maximum. Liver enzyme monitoring before and after use is strongly advised. Do not stack with other 17-AA oral steroids.

Side Effects

  • Significant hepatotoxicity — liver enzyme elevation is rapid; cycle length must be limited to 2-4 weeks; liver monitoring essential
  • Pronounced lethargy and fatigue — often described as the most debilitating side effect; qualitatively similar to Superdrol's lethargy and more pronounced than Dianabol
  • Suppression of natural testosterone — Post Cycle Therapy is required
  • Blood pressure elevation — common and significant; monitor throughout use
  • No aromatisation — no estrogenic side effects; however the high androgenic ratio means acne and hair loss risk exists for predisposed users

Building a Cycle Around M1T

"M1T is formulated at 10mg per tablet — active at doses as low as 5mg/day, making the 10mg tablet highly flexible for users calibrating their first M1T protocol or running the standard 10-20mg/day range."

Storage and Handling

Store M1T at room temperature, away from direct sunlight and moisture. Keep the original packaging sealed until use to maintain tablet potency.

Please log in to write review.

No — this is a common misconception. M1T is the 17-alpha-methylated version of 1-Testosterone (dihydroboldenone/DHB), not of testosterone itself. 1-Testosterone is a structurally distinct compound with a C1-C2 double bond that gives it DHT-like properties. M1T's base is therefore closer to Dihydroboldenone than to testosterone.

Aromatisation requires specific structural features — including the C-19 methyl group that aromatase removes to create estrogen. M1T's parent compound (1-Testosterone) already has a C1-C2 double bond that alters the A-ring structure, making it very resistant to aromatase processing. Without estrogen conversion, there's no estrogen-driven water retention — producing dry, keepable gains rather than Dianabol's wet mass.

Very — documented user reports and case data from M1T's brief legal supplement period (2003-2004) consistently showed significant strength and mass gains at 5-10mg/day, which is unusually potent for an oral steroid. The 10mg Dragon Pharma tablet can be split for a 5mg starting dose recommended for first-time users.

Pronounced fatigue during M1T use is one of its most consistently reported side effects — more debilitating than Dianabol and qualitatively similar to Superdrol's lethargy. The mechanism is not fully characterised but likely involves hepatic and endocrine stress from the compound's extreme potency at the cellular level.

Both produce dry mass gains without aromatisation, but through different base structures. M1T (DHB-derived) has a dramatically higher anabolic ratio (910-1,600 vs Superdrol's 400) but both share pronounced hepatotoxicity and lethargy. M1T generally produces faster and greater mass gains; Superdrol is considered slightly better tolerated at equivalent anabolic effect. Neither should run longer than 4 weeks.

No AI is required — M1T does not aromatise, so there is no estrogen conversion to manage. A SERM (Nolvadex) on hand is still advisable as a precaution given the high androgenic potency, but estrogenic gynecomastia is not a concern with M1T specifically. PCT with Clomid or Nolvadex is required after the cycle to restore natural testosterone.